预混胰岛素在2型糖尿病合并肺部感染患者治疗中的临床疗效

发布时间：2019-03-08 19:18

【摘要】：目的探讨预混胰岛素在2型糖尿病合并肺部感染治疗中的临床疗效,为临床治疗提供参考依据。方法选择医院2015年1月-2016年6月收治的2型糖尿病合并肺部感染患者60例进行研究,按照入院顺序分为研究组和对照组,各30例,所有患者均给予抗感染治疗,对照组采用二甲双胍控制血糖治疗,研究组给予预混胰岛素控制血糖治疗,比较两组临床疗效以及血糖控制情况。结果研究组治疗后C-反应蛋白低于对照组;研究组总有效率为96.7%,高于对照组的70.0%,差异有统计学意义(P0.05);治疗后研究组空腹血糖(FBG)、餐后2h血糖(2hPG)、糖化血红蛋白(HbA1c)水平均显著低于对照组,差异有统计学意义(P0.05)。结论 2型糖尿病合并肺部感染患者采用预混胰岛素控制血糖治疗能有效控制血糖,有利于提高肺部感染治疗的有效率。
[Abstract]:Objective to investigate the clinical efficacy of premixed insulin in the treatment of type 2 diabetes mellitus complicated with pulmonary infection. Methods from January 2015 to June 2016, 60 patients with type 2 diabetes mellitus complicated with pulmonary infection were selected and divided into study group (n = 30) and control group (n = 30). All patients were treated with anti-infection therapy. The patients in the control group were treated with metformin and the patients in the study group were treated with premixed insulin. The clinical efficacy and blood glucose control were compared between the two groups. Results after treatment, the C-reactive protein in the study group was lower than that in the control group, and the total effective rate in the study group was 96.7%, which was higher than that in the control group (70.0%) (P0.05). After treatment, fasting blood glucose (FBG), 2 hours postprandial blood glucose (2hPG) and glycosylated hemoglobin (HbA1c) levels in the study group were significantly lower than those in the control group (P0.05). Conclusion Premixed insulin can effectively control blood glucose in patients with type 2 diabetes mellitus complicated with pulmonary infection, and it is helpful to improve the effective rate of treatment for pulmonary infection.
【作者单位】：内江市中医医院内分泌科;
【分类号】：R563.1;R587.1

【参考文献】